HRP20110200T1 - Uporaba tiotropijevih soli u liječenju umjereno postojane astme - Google Patents
Uporaba tiotropijevih soli u liječenju umjereno postojane astme Download PDFInfo
- Publication number
- HRP20110200T1 HRP20110200T1 HR20110200T HRP20110200T HRP20110200T1 HR P20110200 T1 HRP20110200 T1 HR P20110200T1 HR 20110200 T HR20110200 T HR 20110200T HR P20110200 T HRP20110200 T HR P20110200T HR P20110200 T1 HRP20110200 T1 HR P20110200T1
- Authority
- HR
- Croatia
- Prior art keywords
- treatment
- use according
- patients
- persistent asthma
- preparation
- Prior art date
Links
- 238000011282 treatment Methods 0.000 title claims abstract 12
- 208000006673 asthma Diseases 0.000 title claims abstract 9
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical class O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 title claims abstract 4
- 230000002085 persistent effect Effects 0.000 title claims 8
- 239000003814 drug Substances 0.000 claims abstract 8
- 150000001450 anions Chemical class 0.000 claims abstract 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims abstract 4
- 238000004519 manufacturing process Methods 0.000 claims abstract 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 claims abstract 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims abstract 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims abstract 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910002651 NO3 Inorganic materials 0.000 claims abstract 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims abstract 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims abstract 2
- 229910019142 PO4 Inorganic materials 0.000 claims abstract 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims abstract 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims abstract 2
- 150000004677 hydrates Chemical class 0.000 claims abstract 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims abstract 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims abstract 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract 2
- 239000010452 phosphate Substances 0.000 claims abstract 2
- 239000012453 solvate Substances 0.000 claims abstract 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 claims abstract 2
- 229940095064 tartrate Drugs 0.000 claims abstract 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims abstract 2
- 208000024891 symptom Diseases 0.000 claims 4
- 229940125369 inhaled corticosteroids Drugs 0.000 claims 3
- 101150033809 ADRB2 gene Proteins 0.000 claims 2
- 108020004705 Codon Proteins 0.000 claims 2
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 claims 2
- 229940124748 beta 2 agonist Drugs 0.000 claims 2
- 210000000349 chromosome Anatomy 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 238000012423 maintenance Methods 0.000 claims 2
- 229940127212 long-acting beta 2 agonist Drugs 0.000 claims 1
- 238000011418 maintenance treatment Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 229940110309 tiotropium Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06100055 | 2006-01-04 | ||
| PCT/EP2006/070135 WO2007077162A1 (fr) | 2006-01-04 | 2006-12-22 | Utilisation des sels de tiotropium dans le traitement de l'asthme modéré persistant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110200T1 true HRP20110200T1 (hr) | 2011-04-30 |
Family
ID=35695896
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110200T HRP20110200T1 (hr) | 2006-01-04 | 2011-03-18 | Uporaba tiotropijevih soli u liječenju umjereno postojane astme |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US20070155773A1 (fr) |
| EP (1) | EP1971332B1 (fr) |
| JP (1) | JP2009525950A (fr) |
| KR (1) | KR20080083060A (fr) |
| CN (1) | CN101355937A (fr) |
| AR (1) | AR059126A1 (fr) |
| AT (1) | ATE500825T1 (fr) |
| AU (1) | AU2006334367B2 (fr) |
| BR (1) | BRPI0620886A2 (fr) |
| CA (1) | CA2634984C (fr) |
| CY (1) | CY1111534T1 (fr) |
| DE (1) | DE602006020620D1 (fr) |
| DK (1) | DK1971332T3 (fr) |
| EA (1) | EA015353B1 (fr) |
| EC (1) | ECSP088588A (fr) |
| ES (1) | ES2362306T3 (fr) |
| HR (1) | HRP20110200T1 (fr) |
| IL (1) | IL192602A (fr) |
| ME (1) | ME01205B (fr) |
| MY (1) | MY146362A (fr) |
| NO (1) | NO20082439L (fr) |
| NZ (1) | NZ570162A (fr) |
| PL (1) | PL1971332T3 (fr) |
| PT (1) | PT1971332E (fr) |
| RS (1) | RS51703B (fr) |
| SI (1) | SI1971332T1 (fr) |
| TW (1) | TW200731976A (fr) |
| UA (1) | UA95271C2 (fr) |
| WO (1) | WO2007077162A1 (fr) |
| ZA (1) | ZA200804436B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0614394A2 (pt) | 2005-08-06 | 2011-03-29 | Boehringer Ingelheim Int | uso de sais de tiotrópio |
| WO2015065222A1 (fr) * | 2013-10-28 | 2015-05-07 | Шолекс Девелопмент Гмбх | Préparation pharmaceutique inhalable pour le traitement de l'asthme bronchial et de maladies à obstruction chronique des poumons contenant du bromure de tiotropium micronisé en qualité de substance active, et procédé de production |
| GB201321717D0 (en) * | 2013-12-09 | 2014-01-22 | Pharmachemie Bv | Inhalable Medicaments |
| CN110876721A (zh) * | 2018-09-06 | 2020-03-13 | 天津金耀集团有限公司 | 一种含有表面活性剂的噻托溴铵喷雾剂 |
| CN110876720A (zh) * | 2018-09-06 | 2020-03-13 | 天津金耀集团有限公司 | 依地酸盐恰当改变噻托溴铵喷雾剂表面张力的应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2425539A (en) * | 1942-10-31 | 1947-08-12 | Aro Equipment Corp | Coupling |
| US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US6156503A (en) * | 1997-03-03 | 2000-12-05 | The Regents Of The University Of California | Diagnosing asthma patients predisposed to adverse β-agonist reactions |
| GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
| GB0009583D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
| US6908928B2 (en) * | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| BR0114584A (pt) * | 2000-10-12 | 2003-08-26 | Boehringer Ingelheim Pharma | Monohidrato cristalino, processos para a sua preparação e sua aplicação para a preparação de um medicamento |
| US6608055B2 (en) * | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| US6919325B2 (en) * | 2001-09-14 | 2005-07-19 | Boehringer Ingelheim Pharma Kg | Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts |
| US7951557B2 (en) * | 2003-04-27 | 2011-05-31 | Protalix Ltd. | Human lysosomal proteins from plant cell culture |
| SI1682542T1 (sl) * | 2003-11-03 | 2010-04-30 | Boehringer Ingelheim Int | Nov kristaliniŽŤen anhidrat z antiholinergiŽŤno uŽŤinkovitostjo |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| JP5165244B2 (ja) * | 2003-11-03 | 2013-03-21 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | チオトロピウム塩の製法、チオトロピウム塩及びそれを含有する医薬組成物 |
| SE0303570L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Fukt-känslig medicinsk produkt |
| SE0303571D0 (sv) * | 2003-12-03 | 2003-12-22 | Microdrug Ag | Medical product for moisture-sensitive medicaments |
| AU2006244683A1 (en) * | 2005-05-10 | 2006-11-16 | Synergenz Bioscience Limited | Methods and compositions for assessment of pulmonary function and disorders |
| AU2006248189A1 (en) * | 2005-05-20 | 2006-11-23 | Synergenz Bioscience Limited | Methods of analysis of polymorphisms and uses thereof |
| BRPI0614394A2 (pt) * | 2005-08-06 | 2011-03-29 | Boehringer Ingelheim Int | uso de sais de tiotrópio |
| US20070167480A1 (en) * | 2005-12-19 | 2007-07-19 | Sicor Inc. | Pure and stable tiotropium bromide |
-
2006
- 2006-12-22 DK DK06830792.5T patent/DK1971332T3/da active
- 2006-12-22 BR BRPI0620886-0A patent/BRPI0620886A2/pt not_active Application Discontinuation
- 2006-12-22 MY MYPI20082435A patent/MY146362A/en unknown
- 2006-12-22 CN CNA2006800504685A patent/CN101355937A/zh active Pending
- 2006-12-22 PT PT06830792T patent/PT1971332E/pt unknown
- 2006-12-22 WO PCT/EP2006/070135 patent/WO2007077162A1/fr active Application Filing
- 2006-12-22 CA CA2634984A patent/CA2634984C/fr not_active Expired - Fee Related
- 2006-12-22 NZ NZ570162A patent/NZ570162A/en unknown
- 2006-12-22 EA EA200801629A patent/EA015353B1/ru not_active IP Right Cessation
- 2006-12-22 KR KR1020087019159A patent/KR20080083060A/ko active Search and Examination
- 2006-12-22 EP EP06830792A patent/EP1971332B1/fr not_active Revoked
- 2006-12-22 PL PL06830792T patent/PL1971332T3/pl unknown
- 2006-12-22 JP JP2008548980A patent/JP2009525950A/ja active Pending
- 2006-12-22 ME MEP-2011-62A patent/ME01205B/fr unknown
- 2006-12-22 AT AT06830792T patent/ATE500825T1/de active
- 2006-12-22 UA UAA200809746A patent/UA95271C2/ru unknown
- 2006-12-22 RS RS20110147A patent/RS51703B/en unknown
- 2006-12-22 AU AU2006334367A patent/AU2006334367B2/en active Active
- 2006-12-22 DE DE602006020620T patent/DE602006020620D1/de active Active
- 2006-12-22 SI SI200630986T patent/SI1971332T1/sl unknown
- 2006-12-22 ES ES06830792T patent/ES2362306T3/es active Active
- 2006-12-28 US US11/617,320 patent/US20070155773A1/en not_active Abandoned
-
2007
- 2007-01-03 AR ARP070100019A patent/AR059126A1/es active Pending
- 2007-01-03 TW TW096100183A patent/TW200731976A/zh unknown
-
2008
- 2008-05-22 ZA ZA200804436A patent/ZA200804436B/xx unknown
- 2008-05-28 NO NO20082439A patent/NO20082439L/no not_active Application Discontinuation
- 2008-06-27 EC EC2008008588A patent/ECSP088588A/es unknown
- 2008-07-03 IL IL192602A patent/IL192602A/en active IP Right Grant
-
2011
- 2011-03-18 HR HR20110200T patent/HRP20110200T1/hr unknown
- 2011-06-07 CY CY20111100543T patent/CY1111534T1/el unknown
-
2015
- 2015-04-24 US US14/695,671 patent/US20150224090A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110200T1 (hr) | Uporaba tiotropijevih soli u liječenju umjereno postojane astme | |
| HRP20192114T1 (hr) | Deuterirani derivati ivakaftora | |
| TWI334350B (en) | Cancer treatment | |
| JP2011162556A5 (fr) | ||
| HRP20110232T1 (hr) | Antagonisti muskarinskog acetilkolinskog receptora | |
| CN101686937A (zh) | 用于预防和/或治疗肢体不安宁症的可经由口鼻咽部递送的多巴胺激动剂的药物组合物 | |
| JP2012062329A (ja) | 併用化学療法 | |
| JP2018184465A5 (fr) | ||
| RU2010121827A (ru) | Композиции для лечения болезни паркинсона | |
| JP2013209384A5 (fr) | ||
| CN107847480A (zh) | 呼吸性疾病的治疗 | |
| JP2008503504A5 (fr) | ||
| TW200524639A (en) | Memantine oral dosage forms | |
| WO2009036243A1 (fr) | Nouvelle combinaison d'agents thérapeutiques | |
| AU2009215329B2 (en) | Combination comprising paclitaxel for treating ovarian cancer | |
| JP2014512355A5 (fr) | ||
| US11129836B2 (en) | PAR-4 agonists for the treatment of cancer | |
| CN104418842B (zh) | 取代的吲哚化合物及其使用方法和用途 | |
| KR20150011379A (ko) | 옥시부티닌 투여를 위한 방법 및 조성물 | |
| CN105963244A (zh) | 注射用青蒿琥酯制剂及其应用 | |
| JP2009504604A5 (fr) | ||
| CN107496388A (zh) | 一种含有福莫特罗和噻托铵盐组合物的粉状制剂及其制备方法 | |
| CN114053216A (zh) | 一种吸入用芜地溴铵溶液制剂及其制备方法 | |
| HRP20231131T1 (hr) | Protutumorski farmaceutski pripravci za kombiniranu terapiju | |
| HRP20160420T1 (hr) | Kristalni oblik sukcinatne soli |